Notably, the results exhibited more cancer hallmarks pathways enriched in EBV DNA Sero+ samples, including IFN α/γ response, hypoxia, p53, and TNF-α signaling via NFκ-b pathways (Figure 3E). The gene discussed is NFKB1; the disease is cancer.